Abstract Details

Title Long-Term Benefits of Rivastigmine in Dementia Associated with Parkinson's Disease: An Open-Label Extension Study

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 096

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
	No disclosure on file
Sascha Gill, MSc (University of Calgary)	No disclosure on file
Rosebud O. Roberts, MD (Mayo Clinic)	No disclosure on file

��ɫ����